The pills only hide the symptom. The disease remains.
Across the world, millions of men over forty quietly carry a condition that medicine has long answered with a pill — a temporary fix that treats nothing and ends nothing. In Venezuela, urologist Orangel Pulido has turned to focal shock wave technology to ask a different question: not how to mask vascular damage, but how to reverse it. By prompting the body to grow new blood vessels through precisely directed acoustic energy, this approach reframes erectile dysfunction not as a chronic condition to be managed, but as a wound the body can be guided to heal.
- Between 40 and 50 percent of men over forty live with erectile dysfunction globally, yet most suffer in silence rather than seek care that only offers lifelong pharmaceutical dependence.
- Oral vasodilators — the standard treatment — do nothing to repair the obstructed blood vessels at the root of the problem, leaving patients tethered to medication with no path toward recovery.
- BTL Medical's focal shock wave device disrupts this cycle by delivering precise electroacoustic pulses that trigger neoangiogenesis, coaxing the body into forming new blood vessels and restoring natural function.
- Dr. Pulido became the first urologist in Venezuela to deploy this technology, offering a six-session protocol that is painless, requires no recovery time, and carries no significant side effects.
- Early results suggest mild cases may achieve full independence from medication, moderate cases regain consistency and confidence, and severe cases may delay or avoid surgery altogether.
Dr. Orangel Pulido has spent years watching the same cycle repeat in his Venezuelan urology practice: a patient arrives with erectile dysfunction, leaves with a prescription, and returns — indefinitely — for refills that never resolve anything. The condition affects four to five in every ten men over forty worldwide, yet the standard medical answer remains a vasodilator pill that lasts a day and treats nothing beneath the surface. The obstruction in the blood vessels remains. The dependence deepens.
Pulido's frustration led him to BTL Medical's focal shock wave technology, already in use across more than eighty countries. He became the first urologist in Venezuela to apply it specifically to erectile dysfunction. The principle is rooted in the body's own repair intelligence: high-intensity electroacoustic waves create mechanical stress on vessel walls, which the body reads as a signal to release vascular growth factors and generate new blood vessels — a process called neoangiogenesis. The disease is addressed at its vascular origin, not papered over.
The protocol involves six initial sessions, each painless and requiring no preparation or recovery. Two specialized applicators deliver three thousand precisely distributed pulses per session across six points in the genital area and perineum. At three months, Pulido assesses whether a second cycle is needed. For mild cases, the therapy can eliminate medication entirely. For moderate cases, it restores reliability where pills once failed. For severe cases, it may postpone or prevent surgery.
The technology carries no significant side effects and adapts to patients with clotting disorders through reduced intensity. For Pulido, its deeper value lies in what it returns to the patient: not a chemical crutch, but the body's own capacity to heal. In a country where medical infrastructure is fragile, the fact that BTL maintains local offices and technical support in Venezuela is not a minor detail — it is what makes the promise sustainable.
Dr. Orangel Pulido sits in his urology practice in Venezuela, watching a patient walk out the door without a prescription pad in hand. The man came in struggling with erectile dysfunction—a condition that affects somewhere between four and five of every ten men over forty, though most never speak about it. Pulido has spent years watching patients cycle through the same tired solution: oral medications that work for a few hours, then wear off, then need to be taken again, and again, for the rest of their lives. He decided there had to be another way.
The scale of the problem is staggering. Globally, erectile dysfunction registers a consistent incidence rate between 40 and 50 percent across the male population. In Venezuela and worldwide, millions of men live with this condition, often in silence. The younger demographic—men in their twenties and thirties—experience it at lower rates, around 10 percent, but for different reasons: stress, hormonal imbalances, psychological factors rather than the mechanical breakdown that comes with age. For older men, the culprit is almost always vascular. The blood vessels that feed the erectile tissue become obstructed, narrowed, unable to deliver the flow required for function. Traditional medicine has one answer: vasodilator pills. Take one, get a few hours of relief, repeat indefinitely.
Pulido grew frustrated with this approach. The medications, he explains, are a mask. They hide the symptom for twelve to twenty-four hours, depending on the formulation, but they do nothing to repair the underlying damage. The obstruction remains. The patient remains dependent. There is no cure, only management—a permanent pharmaceutical tether.
Then he discovered BTL Medical's focal shock wave technology, a regenerative approach already deployed in more than eighty countries. Pulido became the first urologist in Venezuela to apply it to erectile dysfunction treatment. The mechanism is elegant: the device emits high-intensity electroacoustic waves in rapid bursts, creating mechanical stress on the inner walls of blood vessels. The body interprets this stress as a signal. It responds by releasing vascular growth factors, triggering a biological process called neoangiogenesis—the formation of new blood vessels and the repair of damaged ones. Blood flow is restored naturally. The disease is treated at its root.
The results vary by severity. For men with mild dysfunction, the therapy can restore vascular function completely, eliminating the need for medication. For those with moderate cases who previously got weak or inconsistent results from pills, the shock waves amplify the biological response, restoring confidence and stability to their intimate lives. For severe cases, the treatment becomes a crucial tool before surgery becomes necessary. Combined with medication, it can sometimes delay or even prevent the need for the operating room.
The protocol is straightforward. A patient undergoes six initial sessions. At three months, Pulido evaluates progress and determines whether a second cycle of six sessions is warranted. Each session is painless. No preparation is needed beforehand. No recovery time is required afterward. A man can walk out and return to work or the gym immediately. The procedure itself is precise: two specialized applicators concentrate the shock waves with millimeter accuracy on the genital area and perineum. The device is programmed to deliver three thousand slow pulses per session, distributed across six specific points—five hundred pulses per point—to stimulate the vessels adequately. When the target is reached, the system stops automatically.
Pulido emphasizes that the technology carries no significant side effects and no absolute contraindications. Patients with recent trauma or surgery simply wait for tissue to consolidate. Those with clotting disorders receive treatment at reduced intensity. The approach is fundamentally friendly to the body, asking it to heal itself rather than imposing a chemical solution. For Pulido, choosing BTL Medical was about quality and commitment—the company maintains local offices in Venezuela, provides technical support, and stands behind its equipment. In a country where medical infrastructure is fragile, that matters. A man no longer has to choose between silence and dependence. He can choose repair.
Notable Quotes
These pills only mask the symptoms for 12 to 24 hours. They don't solve the underlying obstruction, so the patient remains permanently dependent on medication.— Dr. Orangel Pulido
The device emits high-intensity waves that create mechanical stress on blood vessel walls, signaling the body to release growth factors and form new vessels—treating the disease at its vascular root.— Dr. Orangel Pulido
The Hearth Conversation Another angle on the story
Why does this matter now? Erectile dysfunction has been treatable for decades with pills.
The pills don't treat the disease—they treat the symptom for a few hours. A man takes one, it works, it wears off, he takes another. That's not a solution; that's a treadmill. Pulido saw patients trapped in that cycle and wanted to offer them something that actually fixed the problem.
How does mechanical stress on a blood vessel wall convince the body to grow new vessels?
It's a stress response. The body interprets the shock waves as a signal that the tissue needs attention. That triggers the release of growth factors—chemical messengers that say 'build new blood vessels here.' It's regenerative medicine, not pharmaceutical masking.
What happens to the men who try it and it doesn't work?
Pulido evaluates at three months. If the first six sessions don't produce the desired result, he can recommend a second cycle. But the data from his practice shows positive outcomes across the severity spectrum—from mild cases that stop needing pills entirely to severe cases that avoid surgery.
Is this available everywhere, or is it still experimental?
BTL Medical operates in more than eighty countries. Pulido is the pioneer in Venezuela for urological application, but the technology itself is established. It's not experimental—it's a proven alternative that most men simply don't know exists because the pharmaceutical option is so entrenched.
What does a man lose by choosing this over pills?
Nothing, really. No side effects, no recovery time, no ongoing dependence. The only investment is time—six sessions spread across weeks. After that, he either regains function or has a clearer picture of what comes next.
And the men who choose surgery instead?
Some still will. But now they have a choice. Pulido can offer them shock wave therapy first, potentially postponing or eliminating the need for the operating room. That's a significant shift in how the disease is managed.